|
Vittorio Maio, PharmD and Jennifer H.
Lofland, PharmD, MPH; Office of Health Policy and Clinical Outcomes,
Thomas Jefferson University, Philadelphia, USA
The Pharmacoeconomic Fellowship Program
Survey conducted December 2001 was an initiative of the ISPOR Fellowship Task
Force. Even though more than a decade of pharmacoeconomic fellowship programs
have been in existence, the effectiveness of these programs has not been
determined. The objectives of this survey are: a) to determine the
current structure, process, and outcomes of existing fellowship programs, b) to
determine to what extent do these fellowship programs accomplish their role of
augmenting pharmacoeconomic skills and abilities of the recipients, and c) to
determine whether pharmacoeconomic fellowship programs are following published
guidelines such as the American College of Clinical Pharmacy (ACCP) guidelines.
The Taskforce developed a set of three questionnaires, one for fellows
currently enrolled in a fellowship program, one for former fellows who completed
a fellowship program, and one for fellowship preceptors. The survey was
conducted via the ISPOR website. Fellows and preceptors involved in a
pharmacoeconomic fellowship program were identified collecting information from
different sources including the ACCP and ISPOR directories of pharmacoeconomic
fellowships. In addition, participants were recruited through the ISPOR
website, as well as through the ISPOR membership. Survey responses were
collected at the ISPOR website. All collected data are kept confidential in the
study file. A total of 34 current fellows, 68 former fellows, and 49 preceptors
completed the web-based survey.
RESULTS:
A summary of the results were published in Value In Health as a Letter to the
Editor [See: Letter to the Editor. Value Health 2004 7(1),105-6.]
Survey results were presented as a poster
entitled
“Evaluating the Structure of Pharmacoeconomic Fellowship Programs”
(preliminary results) at
the 7th Annual International Meeting in Arlington, VA on May 21 (Poster Session
II, 8:00AM-7:00PM).
The results of this survey were also published in
the American Journal of Pharmaceutical Education 2003; 67(4): article 105 and
can be viewed at:
http://www.ajpe.org/view.asp?art=aj6704105&pdf=yes
The American Journal of Pharmaceutical Education abstract is as follows:
Organizational Structure and Educational Components of Pharmacoeconomic
Fellowship Programs: A Fellows’ Perspective
Vittorio Maio, PharmD a, Jennifer H. Lofland, PharmD, MPH
a, QuynhChau Doan, MS b, Sandeep
Duttagupta, PhD c, Zeba M. Khan, PhD d, Amy L.
Phillips, PharmD e, Sujit S. Sansgiry, PhD f ,Amishi
B. Shah, PharmD g, Jennifer Sung, PharmD h,
and Krista Yokoyama, PharmD i
a Thomas Jefferson University, Office of Health Policy and Clinical
Outcomes, Philadelphia, PA, b University of Texas, College of
Pharmacy, Austin, TX, c Pfizer Inc., Global Outcomes Research Group,
New York, NY, d Novartis Pharma AG, Pharma Affairs, Basel,
Switzerland, e Abbott Laboratories, Center for Pharmaceutical
Appraisal and Outcomes Research, Abbott Park, IL, f University of
Houston, College of Pharmacy, Department of Clinical Sciences and
Administration, Houston, TX,
g Pharmacia Corporation, US Endocrine Care Outcomes Research, Peapack, NJ,
h Novartis Pharmaceuticals Corporation, East Hanover, NJ, i
WellPoint Pharmacy Management, West Hills, CA
ABSTRACT
Objective. The purpose of this study was to describe the organizational
structures and educational components of the pharmacoeconomics and outcomes
research (PE/OR) fellowship programs in the United States.
Methods. A survey questionnaire was administered to current and past fellows of
PE/OR fellowship programs via the International Society for Pharmacoeconomics
and Outcomes Research (ISPOR) web site.
Results. Of the 102 fellows who completed the survey, 71 met the inclusion
criteria. A common profile emerged regarding the organizational and educational
features of PE/OR fellowships. Fellows reported that their PE/OR fellowship
programs were 2 years in length, typically sponsored by the pharmaceutical
industry, and conducted predominantly in academic and pharmaceutical industry
sites. Fellows indicated that their fellowships provided them with a variety of
coursework and a diversity of research skills to enhance their knowledge about
PE/OR.
Conclusions. The characteristics of PE/OR fellowships revealed from this study
may be beneficial for organizations and institutions wishing to develop new or
refine existing programs.
Publication citation:
Maio V, Lofland JH, Doan QC, Duttagupta S, Khan ZM, Phillips AL, Sansgiry
SS, Shah AB, Sung J, Yokoyama K. Organizational Structure and Educational
Components of Pharmacoeconomic Fellowship Programs: A Fellows' Perspective.
Am J Pharm Educ. 2003; 67(4):article 105
|
